Brief: China Medical System Announces Agreements For Strategic Collaboration With Trinomab Biotech
April 19 (Reuters) - China Medical System Holdings Ltd
0867.HK :
* GROUP VIA UNIT SIGNED CERTAIN AGREEMENTS FOR STRATEGIC
COLLABORATION WITH TRINOMAB BIOTECH CO
* GROUP TO MAKE EQUITY INVESTMENT IN & ESTABLISH A JV WITH
TRINOMAB
* GROUP WILL HOLD ABOUT 6.00% EQUITY INTERESTS OF TRINOMAB
Source text https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0418/2021041800009.pdf
Further company coverage: 0867.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Medical System Holdings
See all newsBrief: China Medical System Says CMS-D001 Granted Drug Clinical Trial Approval Notice By NMPA
Brief: China Medical System Holdings Says Dermavon Receives NMPA Approval For Lumirix NDA For Atopic Dermatitis
China Medical System climbs most in six weeks on higher profit, dividend
China Medical System H1 revenue rises on jump in sales of innovative and exclusive products
AI shortens drug discovery to around 1 year in China, Insilico CEO says